Safety and Use of Dydrogesterone in Women with Repeated Miscarriages or Pregnancy Complications
Not Applicable
- Conditions
- Health Condition 1: O092- Supervision of pregnancy with other poor reproductive or obstetric history
- Registration Number
- CTRI/2024/06/068990
- Lead Sponsor
- Torrent Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Pregnant women up to 12 weeks of gestation
2. Women with a history of miscarriage with suspect luteal phase insufficiency
3. Patients willing for follow-up at scheduled visit as per protocol at same center
Exclusion Criteria
1. Known hypersensitivity or contraindication to study drug
2. Heavy vaginal bleeding requiring surgical intervention.
3. Any uterine anomalies.
4. Any associated medical and surgical illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method